Stocktoria
National Vision Holdings, Inc. EYE
Nasdaq · XNAS · stock · Ophthalmic Goods · website · IPO 2017-10-26
National Vision Holdings, Inc. financials (annual, from 10-K)
| Metric | FY2026 | FY2024 | FY2023 | FY2022 | FY2022 |
|---|---|---|---|---|---|
| Revenue | $2.0B | $1.8B | $1.8B | $1.6B | $2.1B |
| SG&A expense | $1.0B | $938.5M | $904.8M | $832.6M | $900.8M |
| Operating income | $58.8M | -$10.4M | $24.5M | $52.8M | $174.9M |
| Income tax | $12.1M | $1.5M | $6.0M | $15.5M | $21.1M |
| Net income | $29.6M | -$28.5M | -$65.9M | $42.1M | $128.2M |
| EPS (diluted) | $0.37 | $-0.36 | $-0.84 | $0.52 | $1.43 |
| Operating cash flow | $146.3M | $133.6M | $173.0M | $119.2M | $258.9M |
| Free cash flow | $73.5M | $38.1M | $58.3M | $5.7M | $163.4M |
| Cash & equivalents | $38.7M | $73.9M | $149.9M | $229.4M | $305.8M |
| Inventory | $89.3M | $93.9M | $119.9M | $123.2M | $123.7M |
| Total assets | $2.0B | $2.0B | $2.2B | $2.3B | $2.3B |
| Shareholders' equity | $869.5M | $816.3M | $829.4M | $901.1M | $926.0M |
Source: SEC EDGAR filings · CIK 0001710155 · as of 2026-01-03. Facts from filings plus Stocktoria's own computed scores — not investment advice.